SCHOTT Pharma AG & Co KgaA banner

SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 14.02 EUR -0.43% Market Closed
Market Cap: €2.1B

Operating Margin

19%
Current
Improving
by 0.1%
vs 3-y average of 18.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19%
=
Operating Income
€186.9m
/
Revenue
€986.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19%
=
Operating Income
€186.9m
/
Revenue
€986.2m

Peer Comparison

Country Company Market Cap Operating
Margin
DE
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
2.1B EUR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
204.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
153.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
35.4B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
36.9B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
31.9B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.3B USD
Loading...
US
Waters Corp
NYSE:WAT
22.8B USD
Loading...

Market Distribution

Higher than 86% of companies in Germany
Percentile
86th
Based on 3 747 companies
86th percentile
19%
Low
-61 459.6% — 0.7%
Typical Range
0.7% — 9.8%
High
9.8% — 94 540%
Distribution Statistics
Germany
Min -61 459.6%
30th Percentile 0.7%
Median 4.5%
70th Percentile 9.8%
Max 94 540%

SCHOTT Pharma AG & Co KgaA
Glance View

SCHOTT Pharma AG & Co KgaA, carved from the renowned SCHOTT AG, stands as a beacon in the pharmaceutical packaging industry. With roots deeply embedded in scientific glass manufacturing, SCHOTT Pharma specializes in providing sophisticated solutions for the containment and delivery of medicines. Their core expertise revolves around the development and production of high-quality glass and polymer products, including pre-fillable syringes, vials, and cartridges. These products are meticulously crafted to meet the stringent safety and quality demands of the healthcare sector, ensuring optimal preservation and delivery of pharmaceutical substances. The company leverages its profound understanding of material science, coupled with a focus on innovation, to offer tailored solutions to pharmaceutical companies across the globe. SCHOTT Pharma's business model thrives on collaboration and partnership with its clients, ensuring their specific needs are met with precision. The firm earns its revenue by forging long-term relationships with leading pharmaceutical players, supplying them with specialized containers designed to enhance drug stability and extend shelf life. This relationship is symbiotic, as SCHOTT Pharma not only provides the physical packaging but also lends its expertise in regulatory compliance and product testing, thereby positioning itself as a crucial contributor to its clients' overall success. By investing deeply in research and development, SCHOTT Pharma continues to innovate, maintaining its competitive edge and ensuring consistent demand for its high-performance pharmaceutical packaging solutions.

1SXP Intrinsic Value
23.82 EUR
Undervaluation 41%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
19%
=
Operating Income
€186.9m
/
Revenue
€986.2m
What is SCHOTT Pharma AG & Co KgaA's current Operating Margin?

The current Operating Margin for SCHOTT Pharma AG & Co KgaA is 19%, which is above its 3-year median of 18.9%.

How has Operating Margin changed over time?

Over the last 2 years, SCHOTT Pharma AG & Co KgaA’s Operating Margin has decreased from 19% to 19%. During this period, it reached a low of 16.8% on Dec 31, 2024 and a high of 20.2% on Dec 31, 2023.

Back to Top